Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147599668> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W3147599668 endingPage "2864" @default.
- W3147599668 startingPage "2858" @default.
- W3147599668 abstract "在紧急情况以后的背景没有回流为尖锐的圣片断举起的经皮的冠的干预(一种总线标准) 心肌的梗塞(STEMI ) 与严重预后有关。这研究的目的是评估 Tongxinluo 的功效，繁体中文药，在在为 219 个病人全部的 STEMI.Methods A 的紧急情况一种总线标准以后的没有回流和梗塞区域上(女性 31 ，14%)从九个临床的中心为 STEMI 经历紧急情况一种总线标准连续地在这被注册使随机化，双窗帘，控制安慰剂， multicenter 对2009年5月的从2007年1月的临床的试用。所有病人随机被划分成 Tongxinluo 在装载的组(n=108 ) 和控制组(n=111 ) ，给定的 Tongxinluo 或安慰剂在紧急情况一种总线标准前分别地为 2.08 g 开 asprin 300 mg 和 clopidogrel 300 mg 一起，然后为在一种总线标准以后的六个月三倍每日的 1.04 g。圣片断举起被心电图在住院记录并且 1， 2， 6， 12，在冠的汽球膨胀到以后的 24 个小时评估心肌的没有流动；在有静态的单个光子的排放的 STEMI 计算了断层摄影术( SPECT )决定在那里的梗塞 area.Results 不是在性别的统计意义以后， 17 个片断的心肌的灌注分数在白天 7 和白天 180 上被评估，年龄经过历史，胸疼痛， onset-to-reperfusion 时间， Killip 分类，就在一种总线标准前后的 TIMI 流动等级，在药治疗的任何一个在follow 在上面期间例如 statin ，-blocker,血管收缩素变换酶禁止者( ACEI )或血管收缩素 rece 在与在 6 个小时的控制组相比的 Tongxinluo 组有重要的圣片断恢复((-0.22????????????????????????????? 慰桴灯票楳汯杯捩污吗？？" @default.
- W3147599668 created "2021-04-13" @default.
- W3147599668 creator A5001978013 @default.
- W3147599668 creator A5002496644 @default.
- W3147599668 creator A5003495875 @default.
- W3147599668 creator A5008108990 @default.
- W3147599668 creator A5018208648 @default.
- W3147599668 creator A5028616130 @default.
- W3147599668 creator A5031774992 @default.
- W3147599668 creator A5041106251 @default.
- W3147599668 creator A5041967787 @default.
- W3147599668 creator A5053122805 @default.
- W3147599668 creator A5053780153 @default.
- W3147599668 creator A5056527366 @default.
- W3147599668 creator A5060073997 @default.
- W3147599668 creator A5060841235 @default.
- W3147599668 creator A5075803984 @default.
- W3147599668 creator A5080536627 @default.
- W3147599668 creator A5088784414 @default.
- W3147599668 date "2010-01-01" @default.
- W3147599668 modified "2023-10-08" @default.
- W3147599668 title "No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo： a randomized double-blind placebo- controlled multicenter clinical trial （ENLEAT Trial）" @default.
- W3147599668 hasPublicationYear "2010" @default.
- W3147599668 type Work @default.
- W3147599668 sameAs 3147599668 @default.
- W3147599668 citedByCount "0" @default.
- W3147599668 crossrefType "journal-article" @default.
- W3147599668 hasAuthorship W3147599668A5001978013 @default.
- W3147599668 hasAuthorship W3147599668A5002496644 @default.
- W3147599668 hasAuthorship W3147599668A5003495875 @default.
- W3147599668 hasAuthorship W3147599668A5008108990 @default.
- W3147599668 hasAuthorship W3147599668A5018208648 @default.
- W3147599668 hasAuthorship W3147599668A5028616130 @default.
- W3147599668 hasAuthorship W3147599668A5031774992 @default.
- W3147599668 hasAuthorship W3147599668A5041106251 @default.
- W3147599668 hasAuthorship W3147599668A5041967787 @default.
- W3147599668 hasAuthorship W3147599668A5053122805 @default.
- W3147599668 hasAuthorship W3147599668A5053780153 @default.
- W3147599668 hasAuthorship W3147599668A5056527366 @default.
- W3147599668 hasAuthorship W3147599668A5060073997 @default.
- W3147599668 hasAuthorship W3147599668A5060841235 @default.
- W3147599668 hasAuthorship W3147599668A5075803984 @default.
- W3147599668 hasAuthorship W3147599668A5080536627 @default.
- W3147599668 hasAuthorship W3147599668A5088784414 @default.
- W3147599668 hasConcept C126322002 @default.
- W3147599668 hasConcept C142724271 @default.
- W3147599668 hasConcept C164705383 @default.
- W3147599668 hasConcept C168563851 @default.
- W3147599668 hasConcept C204787440 @default.
- W3147599668 hasConcept C27081682 @default.
- W3147599668 hasConcept C2777849778 @default.
- W3147599668 hasConcept C2777995511 @default.
- W3147599668 hasConcept C2991744798 @default.
- W3147599668 hasConcept C45393284 @default.
- W3147599668 hasConcept C500558357 @default.
- W3147599668 hasConcept C71924100 @default.
- W3147599668 hasConceptScore W3147599668C126322002 @default.
- W3147599668 hasConceptScore W3147599668C142724271 @default.
- W3147599668 hasConceptScore W3147599668C164705383 @default.
- W3147599668 hasConceptScore W3147599668C168563851 @default.
- W3147599668 hasConceptScore W3147599668C204787440 @default.
- W3147599668 hasConceptScore W3147599668C27081682 @default.
- W3147599668 hasConceptScore W3147599668C2777849778 @default.
- W3147599668 hasConceptScore W3147599668C2777995511 @default.
- W3147599668 hasConceptScore W3147599668C2991744798 @default.
- W3147599668 hasConceptScore W3147599668C45393284 @default.
- W3147599668 hasConceptScore W3147599668C500558357 @default.
- W3147599668 hasConceptScore W3147599668C71924100 @default.
- W3147599668 hasIssue "20" @default.
- W3147599668 hasLocation W31475996681 @default.
- W3147599668 hasOpenAccess W3147599668 @default.
- W3147599668 hasPrimaryLocation W31475996681 @default.
- W3147599668 hasRelatedWork W2062566236 @default.
- W3147599668 hasRelatedWork W2071409595 @default.
- W3147599668 hasRelatedWork W2150503947 @default.
- W3147599668 hasRelatedWork W2261881081 @default.
- W3147599668 hasRelatedWork W2317789011 @default.
- W3147599668 hasRelatedWork W2399738289 @default.
- W3147599668 hasRelatedWork W2491887287 @default.
- W3147599668 hasRelatedWork W2531164240 @default.
- W3147599668 hasVolume "123" @default.
- W3147599668 isParatext "false" @default.
- W3147599668 isRetracted "false" @default.
- W3147599668 magId "3147599668" @default.
- W3147599668 workType "article" @default.